Statistics for Oxford Biomedica PLC (id:3557 OXB)

Valuation metrics

Market cap

436.93M

Enterprise value

464.56M

Trailing P/E (ttm)

Forward P/E

-0.16

PEG ratio

-0.16

Price/Sales (ttm)

4.49

Price/Book (mrq)

650.24

Enterprise Value/Revenue

4.78

Enterprise Value/EBITDA

-8.30

Overview

Shares outstanding

105.92M

Float

69.08M

Shares short

% Held by insiders

0.21%

% Held by institutions

0.65%

Average volume (10 days)

197.81K

Average volume (90 days)

Price summary

52-Week low

164.29

52-Week high

450.00

52-Week change

54.67%

Beta

1.05

50-Day moving average

386.90

200-Day moving average

306.20

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

May 30th, 2018

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

-145.98%

Operating margin

-60.50%

Operational effectiveness

Return on assets

-12.67%

Return on equity

-124.66%

Income statement

Revenue (ttm)

0.96

Revenue per share (ttm)

0.96

Quarterly revenue growth (yoy)

Gross profit (ttm)

39.73M

EBITDA

-55,942,000.00

Net income to common (ttm)

-142,019,008.00

Diluted EPS (ttm)

-1.44

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

81.41M

Total cash per share (mrq)

0.77

Total debt (mrq)

110.31M

Total Debt/Equity (mrq)

154.88

Current ratio (mrq)

234.80%

Book value per share (mrq)

0.63

Cash flow

Cash flow statement

-62,302,000.00

Levered free cash flow (LFCF)

-34,929,624.00